CARGO Therapeutics Announces Appointment of Ginna Laport, MD, as Chief Medical Officer
17 oct. 2023 09h05 HE
|
CARGO Therapeutics, Inc.
— Accomplished clinical leader with significant expertise in hematology/oncology drug development and a track record of advancing multiple modalities of cancer therapeutics — SAN MATEO, Calif., Oct. ...
CARGO Therapeutics Announces Appointment of Michael Ports, PhD, as Chief Scientific Officer
12 sept. 2023 09h05 HE
|
CARGO Therapeutics, Inc.
– Scientific leader with multi-company cell therapy drug development experience spanning early discovery initiatives through late-stage development – SAN MATEO, Calif., Sept. 12, 2023 (GLOBE...
CARGO Therapeutics Appoints Biotech Life Sciences Leaders to Board of Directors
24 août 2023 09h05 HE
|
CARGO Therapeutics, Inc.
– Board of Director appointments follow the Company’s recent launch and $200 million Series A financing in March 2023 – – Appointments include industry veterans John Orwin as Chairman, David Lubner...
CAR T-cell Therapy Market Is Expected to Reach USD 6.1 Billion by 2030, Grow at a CAGR Of 13.5% during Forecast Period 2023 To 2030 | Data By Contrive Datum Insights Pvt Ltd.
30 mars 2023 00h00 HE
|
Contrive Datum Insights Pvt Ltd
Farmington, March 30, 2023 (GLOBE NEWSWIRE) -- The global CAR T-Cell Therapy Market Was Valued at USD 1.7 Billion In 2022, And Is Projected to Reach USD 6.1 Billion By 2030, growing at a CAGR Of...
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market to reach US$ 6.82 Billion by 2033, expanding at a CAGR of 6.9%: Future Market Insights, Inc.
27 mars 2023 20h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
DUBAI, United Arab Emirates, March 27, 2023 (GLOBE NEWSWIRE) -- During the forecast period 2023 to 2033, the Chimeric Antigen Receptor (CAR) T-Cell Therapy Market is expected to grow at a value of...
CAR T-Cell Therapy Market Size to Expand USD 6.43 Bn by 2032
17 janv. 2023 09h51 HE
|
Precedence Research
Ottawa, Jan. 17, 2023 (GLOBE NEWSWIRE) -- The global CAR T-cell therapy market size was valued at USD 2.19 billion in 2022. CAR-T therapy is rapidly expanding due to an increase in cancer cases. For...
CAR T-Cell Therapy Market Predicted to Reach USD 6.1 Billion by 2030 at 13.5% CAGR: Allied Market Research
05 sept. 2022 08h56 HE
|
Allied Market Research
Portland, OR, Sept. 05, 2022 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “CAR T-Cell Therapy Market by Drug type (Axicabtagene Ciloleucel, Tisagenlecleucel, Brexucabtagene...
Certara Announces Collaboration with Leading Cancer Center to Advance CAR T-cell Therapies
28 juil. 2022 08h00 HE
|
Certara
PRINCETON, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a 2-year collaboration with Memorial Sloan Kettering Cancer Center...
NEW LEADING-EDGE TREATMENT FOR LEUKEMIA NOW OFFERED AT NICKLAUS CHILDREN'S HOSPITAL
10 juin 2021 09h54 HE
|
Nicklaus Children's Hospital
MIAMI, June 10, 2021 (GLOBE NEWSWIRE) -- Nicklaus Children's Hospital is one of only a few pediatric hospitals in Florida, and the only one in South Florida, to offer the latest immune cell...
Patients’ Genetically Modified Cells Take Aim at Treating Lymphoma
16 mai 2019 08h00 HE
|
Franciscan Health
INDIANAPOLIS, Indiana, May 16, 2019 (GLOBE NEWSWIRE) -- Franciscan Health cancer doctors are using a new tool to treat patients whose lymphoma has returned after being in remission following...